Literature DB >> 18322019

Loss of prostaglandin E2 release from immortalized urothelial cells obtained from interstitial cystitis patient bladders.

Prerna Rastogi1, Alice Rickard, Nikolay Dorokhov, David J Klumpp, Jane McHowat.   

Abstract

Interstitial cystitis (IC) is associated with increased activated mast cell numbers in the bladder and impairment of the barrier function of the urothelium. We stimulated immortalized urothelial cells derived from the inflamed region of IC bladders (SR22A or SM28 abn) or from healthy bladders (PD07i or PD08i) with tryptase and measured phospholipase A(2) (PLA(2)) activity and the resultant release of arachidonic acid and prostaglandin E(2) (PGE(2)). Tryptase stimulation of either PD07i or SR22A resulted in similar increases in PLA(2) activity and arachidonic acid release. However, tryptase stimulation of SR22A and SM28 abn did not result in a significant increase in PGE(2) release compared with the increase in PGE(2) release from tryptase-stimulated PD07i and PD08i cells. Expression of mRNA for cyclooxygenase-2 and PGE synthase was lower and mRNA for 15-hydroxyprostaglandin dehydrogenase was higher in SR22A compared with PD07i, suggesting that both decreased synthesis and increased metabolism are responsible for the lack of a PGE(2) response in tryptase-stimulated SR22A cells. Since PGE(2) is a cytoprotective eicosanoid, the failure to produce this metabolite in cells isolated from the IC bladder may represent an increased susceptibility to damage by proinfammatory stimuli.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18322019      PMCID: PMC2830562          DOI: 10.1152/ajprenal.00572.2007

Source DB:  PubMed          Journal:  Am J Physiol Renal Physiol        ISSN: 1522-1466


  41 in total

1.  Role of PAR2 in pain and inflammation.

Authors:  Stefano Fiorucci; Eleonora Distrutti
Journal:  Trends Pharmacol Sci       Date:  2002-04       Impact factor: 14.819

2.  Loss of 15-hydroxyprostaglandin dehydrogenase expression disrupts urothelial differentiation.

Authors:  Stephanie Tseng-Rogenski; I-Ling Lee; Daniel Gebhardt; Susan M Fischer; Christopher Wood; John M Park; Monica Liebert
Journal:  Urology       Date:  2008-02       Impact factor: 2.649

3.  Prostaglandin E(2) regulates wound closure in airway epithelium.

Authors:  U Savla; H J Appel; P H Sporn; C M Waters
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2001-03       Impact factor: 5.464

4.  Proteinase-activated receptor 2 is an anti-inflammatory signal for colonic lamina propria lymphocytes in a mouse model of colitis.

Authors:  S Fiorucci; A Mencarelli; B Palazzetti; E Distrutti; N Vergnolle; M D Hollenberg; J L Wallace; A Morelli; G Cirino
Journal:  Proc Natl Acad Sci U S A       Date:  2001-11-20       Impact factor: 11.205

5.  Recruitment, distribution and phenotypes of mast cells in interstitial cystitis.

Authors:  R Peeker; L Enerbäck; M Fall; F Aldenborg
Journal:  J Urol       Date:  2000-03       Impact factor: 7.450

6.  Carbon monoxide attenuates aeroallergen-induced inflammation in mice.

Authors:  J T Chapman; L E Otterbein; J A Elias; A M Choi
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2001-07       Impact factor: 5.464

7.  Uropathogenic Escherichia coli potentiates type 1 pilus-induced apoptosis by suppressing NF-kappaB.

Authors:  D J Klumpp; A C Weiser; S Sengupta; S G Forrestal; R A Batler; A J Schaeffer
Journal:  Infect Immun       Date:  2001-11       Impact factor: 3.441

8.  Phospholipid metabolite production in human urothelial cells after protease-activated receptor cleavage.

Authors:  Alice Rickard; Jane McHowat
Journal:  Am J Physiol Renal Physiol       Date:  2002-11

9.  Cyclooxygenase-2 protein and prostaglandin E(2) production are up-regulated in a rat bladder inflammation model.

Authors:  M A Wheeler; J H Yoon; L E Olsson; R M Weiss
Journal:  Eur J Pharmacol       Date:  2001-04-13       Impact factor: 4.432

10.  Prostaglandin E2 production and cyclooxygenase-2 induction in human urinary tract infections and bladder cancer.

Authors:  Marcia A Wheeler; Derek A Hausladen; Jeong H Yoon; Robert M Weiss
Journal:  J Urol       Date:  2002-10       Impact factor: 7.450

View more
  5 in total

Review 1.  Cystitis, co-morbid disorders and associated epithelial dysfunction.

Authors:  Lori A Birder; Ann T Hanna-Mitchell; Emeran Mayer; Charles A Buffington
Journal:  Neurourol Urodyn       Date:  2011-06       Impact factor: 2.696

Review 2.  Research Findings on Overactive Bladder.

Authors:  Phani B Patra; Sayani Patra
Journal:  Curr Urol       Date:  2015-05-20

3.  Changes in prostaglandin E2 in patients with idiopathic overactive bladder syndrome after botulinum toxin type A treatment: is there a clinical benefit?

Authors:  Axel Hegele; Sonja Knippschild; Carsten Frohme; Jörg Hänze; Peter Olbert; Rainer Hofmann
Journal:  BMC Urol       Date:  2014-11-04       Impact factor: 2.264

4.  Impaired Expression of Prostaglandin E2 (PGE2) Synthesis and Degradation Enzymes during Differentiation of Immortalized Urothelial Cells from Patients with Interstitial Cystitis/Painful Bladder Syndrome.

Authors:  John O Marentette; Robert E Hurst; Jane McHowat
Journal:  PLoS One       Date:  2015-06-09       Impact factor: 3.240

5.  Tryptase activation of immortalized human urothelial cell mitogen-activated protein kinase.

Authors:  John O Marentette; Paul J Hauser; Robert E Hurst; David J Klumpp; Alice Rickard; Jane McHowat
Journal:  PLoS One       Date:  2013-07-29       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.